Does timing of initial surfactant treatment make a difference in rates of chronic lung disease or mortality in premature infants? An observational regional study

Refrences

• Soll RF. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2010. Art. No.: CD000511. doi:10.1002/14651858.CD000511
   Web of Science ®Google Scholar
• Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2009: CD001456
   Web of Science ®Google Scholar
• Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007: CD003063
   Web of Science ®Google Scholar
• Soll RF. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 1998: CD001079
   Google Scholar
• Soll RF, Morley CJ. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012: CD000510
   Web of Science ®Google Scholar
• Rojas MA, Lozano JM, Rojas MX, Laughon M, et al; Colombian Neonatal Research Network. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics 2009;123:137–42
   PubMed Web of Science ®Google Scholar
• Gortner L, Wauer RR, Hammer H, Stock GJ, et al. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks’ gestational age: a multicenter controlled clinical trial. Pediatrics 1998;102:1153–60
   PubMed Web of Science ®Google Scholar
• Morley CJ, Davis PG, Doyle LW, Brion LP, et al. Nasal CPAP or intubation at birth for very preterm infants. NEJM 2008;358:700–8
   PubMed Web of Science ®Google Scholar
• The Texas Neonatal Research Group. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. J Pediat 2004;144:804–8
   PubMed Web of Science ®Google Scholar
• Dunn MS, Shennan AT, Zyack D, Possmayer F. Bovine surfactant replacement therapy in neonates of less than 30 weeks’ gestation: a randomized controlled trial of prophylaxis vs. treatment. Pediatrics 1991;87:377–86
   PubMed Web of Science ®Google Scholar
• Kendig JW, Notter RH, Cox C, et al. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks’ gestation. NEJM 1991;324:865–71
   PubMed Web of Science ®Google Scholar
• Kattwinkel J, Bloom BT, Delmore P, et al. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks’ gestation. Pediatrics 1993;92:90–8
   PubMed Web of Science ®Google Scholar
• Egberts J, DeWinter JP, Sedin G, et al. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks’ gestation: a randomized trial. Pediatrics 1993;92:768–74
   PubMed Web of Science ®Google Scholar
• Bevilacqua G, Parmigiani S, Robertson B, the Italian Collaborative Multicentre Study Group. Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial. J Perinat Med 1996;24:1–12
   Web of Science ®Google Scholar
• Bevilacqua G, Chernev T, Parmigiani S, et al. Use of surfactant for prophylaxis versus rescue treatment of respiratory distress syndrome: experience from an Italian–Bulgarian trial. Acta Biomed Ateneo Parmense 1997;68:47–54
   PubMedGoogle Scholar
• Walti H, Paris-Llado J, Breart G, Couchard M, the French Collaborative Multicentre Study Group. Porcine surfactant replacement therapy in newborns of 25–31 weeks’ gestation: a randomized multicentre trial of prophylaxis versus rescue with multiple low doses. Acta Paediat 1995;84:913–21
   PubMed Web of Science ®Google Scholar
• Konishi M, Fujiwara T, Chida S, et al. A prospective randomized trial of early versus late administration of a single dose of surfactant-TA. Early Hum Dev 1992;29:275–82
   PubMed Web of Science ®Google Scholar
• Finer NN, Carlo WA, Walsh MC, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010;362:1970–9
   PubMed Web of Science ®Google Scholar
• The OSIRIS Collaborative Group. Early versus delayed neonatal administration of a synthetic surfactant – the judgement of OSIRIS. Lancet 1992;340:1363–9
   PubMed Web of Science ®Google Scholar
• European Exosurf Study Group. Early or selective surfactant (Colfosceril Palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation: a European double-blind trial with sequential analysis. Online J Curr Clin Trials. 1992: Doc. No. 28
   Google Scholar
• Bajuk B. Validation of the neonatal intensive care units’ data collection. Proceedings of the 5th Annual Conference of the Perinatal Society of Australia and New Zealand. Canberra, ACT, Australia: The Perinatal Society of Australia and New Zealand; 2001
   Google Scholar
• Lui K, Abdel-Latif ME, Allgood CL, et al. Improved outcomes of extremely premature outborn Infants: effects of strategic changes in perinatal and retrieval services. Pediatrics 2006;118:2076–83
   PubMed Web of Science ®Google Scholar
• Abdel-Latif ME, Bajuk B, Oei J, Lui K, the Neonatal Intensive Care Units Group. Mortality and morbidities among very premature infants admitted after-hours in an Australian neonatal intensive care unit network. Pediatrics 2006;117:1632–9
   PubMed Web of Science ®Google Scholar
• Rashid A, Bhuta T, Berry A. A regionalised transport service: the way ahead? Arch Dis Child 1999;80:488–92
   PubMed Web of Science ®Google Scholar
• National Health and Medical Research Council. Clinical practice guidelines: care around preterm birth. Canberra, Australia: National Health and Medical Research Council; 1997
   Google Scholar
• Abdel-Latif ME, Berry A. Analysis of the retrieval times of a centralised transport service, New South Wales, Australia. Arch Dis Child 2009;94:282–6
   PubMed Web of Science ®Google Scholar
• Sandri F, Plavka R, Ancora G, et al. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010;125:e1402–9
   PubMed Web of Science ®Google Scholar
• SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010;362:1970–9
   PubMed Web of Science ®Google Scholar
• Shennan AT, Dunn MS, Ohlsson A, et al. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82:527–32
   PubMed Web of Science ®Google Scholar
• Jobe AH, Bancalari E. NICHD/NHLBI/ORD workshop summary: bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723–9
   PubMedGoogle Scholar
• Papile LA, Burnstein J, Burnstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 g. J Pediatr 1978;92:529–34
   PubMed Web of Science ®Google Scholar
• Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1–7
   PubMed Web of Science ®Google Scholar
• Flynn J. An international classification of retinopathy of prematurity: clinical experience. Trans Am Ophthalmol Soc 1984;82:218–38
   PubMedGoogle Scholar
• Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: John Wiley; 2000
   Google Scholar
• Aitkin MD, Francis AB, Hinde J. Statistical modelling in GLIM. Oxford: Oxford Science Publications; 1989
   Google Scholar
• European Exosurf Study Group. Early or selective surfactant (Colfosceril Palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation: a European double-blind trial with sequential analysis. Online J Curr Clin Trials 1992; Doc 28
   Google Scholar
• Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012: CD000510
   Web of Science ®Google Scholar
• Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006: CD004454
   Web of Science ®Google Scholar
• Ingimarsson J, Bjorklund LJ, Curstedt T, et al. Incomplete protection by prophylactic surfactant against the adverse effects of large lung inflations at birth in immature lambs. Intensive Care Med 2004;30:1446–53
   PubMed Web of Science ®Google Scholar
• Dunn MS, Kaempf J, de Klerk A, et al. for the Vermont Oxford Network DRM Study Group. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics 2011;128:e1069–76
   PubMed Web of Science ®Google Scholar
• Halliday HL. What interventions facilitate weaning from the ventilator? A review of the evidence from systematic reviews. Paediatr Respir Rev 2004;5:S347–52
   PubMedGoogle Scholar
• Schuman TA, Jacobs B, Walsh W, Goudy SL. Iatrogenic perinatal pharyngoesophageal injury: a disease of prematurity. Int J Pediatr Otorhinolaryngol 2010;74:393–7
   PubMed Web of Science ®Google Scholar
• Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2009: CD007836
   PubMed Web of Science ®Google Scholar
• Abdel-Latif ME, Osborn DA. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome [Review]. Cochrane Database Syst Rev 2012: CD008310
   PubMed Web of Science ®Google Scholar
• Abdel-Latif ME, Osborn DA, Challis D. Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns [Review]. Cochrane Database Syst Rev 2010: CD007916
   PubMed Web of Science ®Google Scholar
• Abdel-Latif ME, Osborn DA. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome [Review]. Cochrane Database Syst Rev 2011: CD008309
   Web of Science ®Google Scholar
• Abdel-Latif ME, Osborn DA. Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome [Review]. Cochrane Database Syst Rev 2011: CD008311
   Web of Science ®Google Scholar
• Wheeler K, Abdel-Latif ME, De Paoli T, et al. Surfactant via brief tracheal catheterisation for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome [Protocol]. Cochrane Database Syst Rev (in press)
   Web of Science ®Google Scholar
• Editors. Potential selection bias in hospital-based studies of perinatal outcome. Paediatr Perinat Epidemiol 2004;18:153
   PubMed Web of Science ®Google Scholar
• Sackett DL. Bias in analytic research. J Chronic Dis 1979;32:51–63
   PubMedGoogle Scholar